Ads
related to: biotechnology
Search results
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 4 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
IMC Chicago LLC Purchases New Stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
ETF DAILY NEWS· 4 days agoIMC Chicago LLC bought a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) in the 4th quarter, according to the company in its ...
Semiconductors Shine, But Outlook for Other Sectors Remains Mixed | Investing.com
Investing.com· 20 hours agoStocks Analysis by Michele Schneider covering: US Small Cap 2000, iShares Biotechnology ETF, NVIDIA...
Lone Star College invests $500K into Montgomery campus' biotechnology program
Community Impact· 3 days agoThe Lone Star College-Montgomery Biotechnology Institute will be expanding its offerings and...
Traders Buy Large Volume of Put Options on iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 4 days agoiShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 70,278 put options on ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Commerce Bank
ETF DAILY NEWS· 17 hours ago(NASDAQ:BMRN – Free Report) by 7.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 36,569 shares of the biotechnology company’s stock after selling 3,050 ...
Adaptive Biotechnologies Corp (ADPT) Shares Down Despite Recent Market Volatility – News Heater
NewsHeater· 5 days agoAdaptive Biotechnologies Corp (NASDAQ: ADPT)’s stock price has decreased by -3.16 compared to its previous closing price of 3.46. Is It Worth Investing in Adaptive Biotechnologies Corp (NASDAQ ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 9 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Genmab acquires biotechnology company ProfoundBio in $1.8bn deal
Pharmaceutical Technology via Yahoo Finance· 6 days agoGenmab has concluded the previously announced acquisition of clinical-stage biotechnology company...
Sana Biotechnology Inc (NASDAQ: SANA) Is Up 111.52% Year-To-Date, But Analysts Find Room For A Price...
Stocks Register· 7 days agoSana Biotechnology Inc (NASDAQ:SANA) traded at $8.63 at close of the session on Monday, May 20, made a downward move of -1.15% on its previous day’s price. Looking at the ...